4.5 Article

Kaempferol is an estrogen-related receptor α and γ inverse agonist

期刊

FEBS LETTERS
卷 583, 期 4, 页码 643-647

出版社

WILEY
DOI: 10.1016/j.febslet.2009.01.030

关键词

Estrogen receptor; Estrogen-related receptor; Kaempferol

资金

  1. National Science Foundation of China [30672463]
  2. Chinese National Science and Technology Department [2006CB50390]
  3. Chinese Academy of Sciences [KSCX2-YW-R-085]
  4. GIBH

向作者/读者索取更多资源

Kaempferol is a dietary flavonoid that is thought to function as a selective estrogen receptor modulator. In this study, we established that kaempferol also functions as an inverse agonist for estrogen-related receptors alpha and gamma (ERR alpha and ERR gamma). We demonstrated that kaempferol binds to ERR alpha and ERR gamma and blocks their interaction with coactivator peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1 alpha). Kaempferol also suppressed the expressions of ERR-target genes pyruvate dehydrogenase kinase 2 and 4 (PDK2 and PDK4). This evidence suggests that kaempferol may exert some of its biological effect through both estrogen receptors and estrogen-related receptors. (C) 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Chemistry, Multidisciplinary

The m6A demethylase FTO promotes the osteogenesis of mesenchymal stem cells by downregulating PPARG

Liu-shan Chen, Meng Zhang, Peng Chen, Xiao-feng Xiong, Pei-qing Liu, Hai-bin Wang, Jun-jian Wang, Juan Shen

Summary: This study investigates the role of m(6)A modification in osteogenesis and reveals the functional significance of the FTO-PPARG axis in promoting the osteogenesis of human MSCs. It also sheds light on the role of m(6)A modification in mediating osteoporosis and osteonecrosis.

ACTA PHARMACOLOGICA SINICA (2022)

Article Chemistry, Multidisciplinary

The novel indomethacin derivative CZ-212-3 exerts antitumor effects on castration-resistant prostate cancer by degrading androgen receptor and its variants

Hong Wang, Zhe Chang, Guo-di Cai, Ping Yang, Jiang-he Chen, Shan-shu Yang, Yin-feng Guo, Ming-yu Wang, Xue-hua Zheng, Jin-ping Lei, Pei-qing Liu, De-peng Zhao, Jun-jian Wang

Summary: A series of novel indomethacin derivatives were evaluated for their anti-tumor effects in castration-resistant prostate cancer, with CZ-212-3 showing the most potent efficacy by degrading AR and its variants to inhibit tumor growth.

ACTA PHARMACOLOGICA SINICA (2022)

Article Cell Biology

Targeting autophagy peptidase ATG4B with a novel natural product inhibitor Azalomycin F4a for advanced gastric cancer

Lin Zhong, Bin Yang, Zhenhua Zhang, Junfeng Wang, Xiaojuan Wang, Yinfeng Guo, Weifeng Huang, Qianqian Wang, Guodi Cai, Fan Xia, Shengning Zhou, Shuai Ma, Yichu Nie, Jinping Lei, Min Li, Peiqing Liu, Wenbin Deng, Yonghong Liu, Fanghai Han, Junjian Wang

Summary: This study found that autophagy-related gene 4B (ATG4B) was overexpressed in advanced gastric cancer (GCa) tumors and was associated with poor prognosis. Researchers identified Azalomycin F4a (Am-F4a) as a potent ATG4B inhibitor through screening a natural compound library. Am-F4a effectively inhibited GCa cell autophagy by directly binding to and inhibiting ATG4B, leading to suppressed tumor growth and reduced cell migration and invasion. Additionally, Am-F4a sensitized tumors to chemotherapy.

CELL DEATH & DISEASE (2022)

Article Pharmacology & Pharmacy

Nuclear TIGAR mediates an epigenetic and metabolic autoregulatory loop via NRF2 in cancer therapeutic resistance

Hong Wang, Qianqian Wang, Guodi Cai, Zhijian Duan, Zoann Nugent, Jie Huang, Jianwei Zheng, Alexander D. Borowsky, Jian Jian Li, Peiqing Liu, Hsing-Jien Kung, Leigh Murphy, Hong-Wu Chen, Junjian Wang

Summary: Metabolic and epigenetic reprogramming contribute to cancer therapeutic resistance. In this study, it was found that TIGAR, an antioxidant and glucose metabolic regulator, interacts with NRF2 to stimulate NSD2 expression. Nuclear accumulation of TIGAR is associated with therapeutic resistance and poor survival.

ACTA PHARMACEUTICA SINICA B (2022)

Article Pharmacology & Pharmacy

Therapeutic targeting RORγ with natural product N-hydroxyapiosporamide for small cell lung cancer by reprogramming neuroendocrine fate

Jianghe Chen, Yiwei Hu, Jian Zhang, Qianyu Wang, Xiongzhi Wu, Weiye Huang, Qianqian Wang, Guodi Cai, Hong Wang, Tianmiao Ou, Weineng Feng, Peiqing Liu, Yonghong Liu, Junfeng Wang, Jie Huang, Junjian Wang

Summary: This study reveals the function of RAR-related orphan receptor gamma (RORγ) in small cell lung cancer (SCLC) and identifies the anti-cancer activity of its natural inhibitor, N-hydroxyapiosporamide (N-hydap). The findings show that depletion of RORγ affects cell growth in SCLC and N-hydap inhibits RORγ activity, leading to reprogramming of neuroendocrine fate. The study suggests that RORγ could be a potential target for SCLC and N-hydap may be a promising therapeutic drug candidate.

PHARMACOLOGICAL RESEARCH (2022)

Article Microbiology

Kynurenine-3-monooxygenase (KMO) broadly inhibits viral infections via triggering NMDAR/Ca2+ influx and CaMKII/IRF3-mediated IFN-β production

Jin Zhao, Jiaoshan Chen, Congcong Wang, Yajie Liu, Minchao Li, Yanjun Li, Ruiting Li, Zirong Han, Junjian Wang, Ling Chen, Yuelong Shu, Genhong Cheng, Caijun Sun

Summary: The key enzyme KMO and its metabolite QUIN show promise as novel broad-spectrum antiviral factors, inhibiting viral infections and disease progression by modulating calcium signaling pathways and interferon production. These findings have important implications for the development of new antiviral drugs.

PLOS PATHOGENS (2022)

Article Biochemistry & Molecular Biology

Inhibition of STAT3-ferroptosis negative regulatory axis suppresses tumor growth and alleviates chemoresistance in gastric cancer

Shumin Ouyang, Huaxuan Li, Linlin Lou, Qiuyao Huang, Zhenhua Zhang, Jianshan Mo, Min Li, Jiaye Lu, Kai Zhu, Yunjie Chu, Wen Ding, Jianzheng Zhu, Ziyou Lin, Lin Zhong, Junjian Wang, Peibin Yue, James Turkson, Peiqing Liu, Yuanxiang Wang, Xiaolei Zhang

Summary: Inhibition of STAT3 can trigger ferroptosis and provide a new therapeutic strategy for gastric cancer and chemotherapy resistance. STAT3 negatively regulates the FNR associated genes and establishes a negative STAT3-ferroptosis regulatory axis in gastric cancer. A selective STAT3 inhibitor, W1131, shows significant anti-tumor effects in gastric cancer models by inducing ferroptosis and restores sensitivity to chemotherapy.

REDOX BIOLOGY (2022)

Article Chemistry, Multidisciplinary

Discovery of Highly Potent Daphnane Diterpenoids Uncovers Importin-β1 as a Druggable Vulnerability in Castration-Resistant Prostate Cancer

Jia-Luo Huang, Xue-Long Yan, Wei Li, Run-Zhu Fan, Shen Li, Jianghe Chen, Zhenhua Zhang, Jun Sang, Lu Gan, Gui-Hua Tang, Hongwu Chen, Junjian Wang, Sheng Yin

Summary: This study identified a highly potent importin-beta 1 inhibitor DD1, which selectively inhibited the growth and survival of CRPC cells and completely blocked tumor growth. Mechanistic studies showed that DD1 reduced the nuclear accumulation of key CRPC drivers, shutting down their downstream oncogenic signaling. These findings suggest that importin-beta 1 is an effective therapeutic target in CRPC and DD1 can be developed as a potential treatment for this disease.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2022)

Article Biochemistry & Molecular Biology

Cyclohexenone Derivative and Drimane Sesquiterpenes from the Seagrass-Derived Fungus Aspergillus insuetus

Zhibo Hu, Junjie Chen, Qianqian Liu, Qilin Wu, Shenhua Chen, Junjian Wang, Jing Li, Lan Liu, Zhizeng Gao

Summary: One new cyclohexenone derivative (1) and two undescribed drimane sesquiterpenes (2 and 3), along with seven known drimane sesquiterpenes, were isolated from a seagrass-derived fungus Aspergillus insuetus SYSU6925. The structures of these metabolites were determined through comprehensive spectroscopic analysis. Compounds 1-3, 5, and 7 exhibited weak to moderate antifungal activities against four phytopathogenic fungi, with MIC values ranging from 50 to 200 mu g/mL. Compound 1, a rare cyclohexenone derivative with an n-propyl group, showed more potent inhibitory activities (MIC, 50 mu g/mL) against F. oxysporum compared to the positive control (Triadimefon). Compounds 2 and 3 also demonstrated potent anti-inflammatory activities by inhibiting nitric oxide (NO) production in RAW264.7 cells with IC50 values of 21.5 +/- 1.1 and 32.6 +/- 1.16 mu M, respectively.

CHEMISTRY & BIODIVERSITY (2023)

Article Chemistry, Medicinal

Structure-Based Design and Characterization of the Highly Potent and Selective Covalent Inhibitors Targeting the Lysine Methyltransferases G9a/GLP

Zongbo Feng, Chunju Yang, Yi Zhang, Huaxuan Li, Wei Fang, Junhua Wang, Yichu Nie, Chang-Yun Wang, Zhiqing Liu, Zhimin Jiang, Junjian Wang, Yuanxiang Wang

Summary: Protein lysine methyltransferases G9a and GLP are important in cellular processes. A covalent inhibitor, compound 27, has been discovered to effectively inhibit cell proliferation and reduce H3K9me2 levels. It also shows significant antitumor efficacy in vivo.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Multidisciplinary Sciences

The binding mode of orphan glycyl-tRNA synthetase with tRNA supports the synthetase classification and reveals large domain movements

Lu Han, Zhiteng Luo, Yingchen Ju, Bingyi Chen, Taotao Zou, Junjian Wang, Jun Xu, Qiong Gu, Xiang-Lei Yang, Paul Schimmel, Huihao Zhou

Summary: Aminoacyl-transfer RNA (tRNA) synthetases (aaRSs) are essential enzymes in protein translation, categorized into two classes with distinct active site architectures. The orphan GlyRS in bacteria has a unique X-shaped structure. A cocrystal structure elucidates how this orphan GlyRS specifically recognizes its substrate tRNA. The X shape of orphan GlyRS suggests potential nonactive site targets for aaRS-directed antibiotics.

SCIENCE ADVANCES (2023)

Article Biochemistry & Molecular Biology

Marine fungus-derived alkaloid inhibits the growth and metastasis of gastric cancer via targeting mTORC1 signaling pathway

Shuai Ma, Yiwei Hu, Jianjiao Chen, Xiaojuan Wang, Chenxi Zhang, Qianqian Liu, Guodi Cai, Hong Wang, Jianwei Zheng, Qianqian Wang, Lin Zhong, Bin Yang, Shengning Zhou, Yonghong Liu, Fanghai Han, Junjian Wang, Junfeng Wang

Summary: A novel compound named arthpyrone M (Art-M) derived from marine fungus Arthrinium arundinis showed potential antitumor activity against gastric cancer (GC) by inhibiting cell proliferation, invasion, and migration. The mechanism was found to be through suppressing the mTORC1 pathway. Additionally, Art-M enhanced the sensitivity of GC cells to apatinib and showed better efficacy when used in combination.

CHEMICO-BIOLOGICAL INTERACTIONS (2023)

Article Immunology

Flot2 deficiency facilitates B cell-mediated inflammatory responses and endotoxic shock

Qin Yang, Zhenhua Zhang, Ziye Chen, Yiyuan Wang, Yan Chen, Jiehuang Zheng, Ruopeng Li, Lihong Li, Lixia Mo, Qinghe Liang, Fengsheng Chen, Junjian Wang, Xiaojuan Li

Summary: The study reveals that Flot2 gene expression is significantly reduced in B cells from patients with bacterial sepsis and endotoxin-induced septic mice. Flot2 deficiency aggravates sepsis by facilitating effector B cells rather than regulatory B cells, leading to increased inflammation and lung injury. These findings highlight the importance of Flot2 as a novel controller of B cells in the pathogenesis and progression of sepsis.

IMMUNOLOGY (2023)

Article Biochemistry & Molecular Biology

Cytotoxic pyridine alkaloids from a marine-derived fungus Arthrinium arundinis exhibiting apoptosis-inducing activities against small cell lung cancer

Yiwei Hu, Shuai Ma, Xiaoyan Pang, Mengjing Cong, Qianqian Liu, Fanghai Han, Junjian Wang, Weineng Feng, Yonghong Liu, Junfeng Wang

Summary: Small cell lung cancer (SCLC) is a high-grade neuroendocrine carcinoma that has a higher proliferative rate, earlier metastasis, and poorer outcomes compared to non-small cell lung cancer (NSCLC). Through molecular networking, new pyridone alkaloids were discovered and evaluated for their cytotoxicity against cancer cell lines. One of the alkaloids, arthpyrone O showed potent efficacy against SCLC cells in vitro and inhibited tumor growth in vivo, suggesting its potential as a drug discovery scaffold.

PHYTOCHEMISTRY (2023)

Article Pharmacology & Pharmacy

Discovery of a highly potent and orally available importin-β1 inhibitor that overcomes enzalutamide-resistance in advanced prostate cancer

Jia-Luo Huang, Xue-Long Yan, Dong Huang, Lu Gan, Huahua Gao, Run-Zhu Fan, Shen Li, Fang-Yu Yuan, Xinying Zhu, Gui-Hua Tang, Hong-Wu Chen, Junjian Wang, Sheng Yin

Summary: The study optimized a natural importin-beta 1 inhibitor DD1 to improve its tolerability and oral bioavailability, resulting in an analog called DD1-Br. DD1-Br exhibited potent inhibition of survival in castration-resistant prostate cancer cells and effectively prevented tumor growth in resistant CRPC models. Mechanistic study revealed that DD1-Br targeted importin-beta 1 and suppressed the nuclear accumulation of key CRPC drivers, including AR-V7, thereby inhibiting oncogenic signaling.

ACTA PHARMACEUTICA SINICA B (2023)

暂无数据